Biologics superior to conventional psoriasis treatment

Reviewers canvassed 48 trials on eight different systemic treatments, concluding infliximab, adalimumab and ustekinumab were the most efficacious options compared to etanercept, alefacept, MTX, CSA, retinoids and fumaric acid esters.